Company Overview
- Headquarters
- 257 Life Sciences Facility, Clemson University - Clemson SC
- Website
- clemson.edu/centers-institutes/epic
- Employees
- 23
- Founded in
- 2013
- Industry
- Scientific Research
Financials & Stats
Revenue
$50B
Who is Clemson University Eukaryotic Pathogens Innovation Center
Clemson University Eukaryotic Pathogens Innovation Center is a research cooperative located at Clemson University in Clemson, South Carolina. The center employs 23 people and generates $50 million in annual revenue. The Eukaryotic Pathogens Innovation Center (EPIC) focuses on biomedical research concerning eukaryotic pathogens, the organisms responsible for serious diseases such as malaria, amoebic dysentery, sleeping sickness, Chagas disease, and fungal meningitis. Their research aims to understand and combat these pathogens, which are a growing threat due to globalization and their potential as bioterrorism agents or neglected tropical diseases (NTDs). EPIC's faculty members are dedicated to making significant contributions to this critical area of research, bringing extensive experience and a strong track record of success. For more information, please visit clemson.edu/centers-institutes/epic.
Companies Similar to Clemson University Eukaryotic Pathogens Innovation Center
Analyze industry trends and opportunities by examining competitors and companies comparable to Clemson University Eukaryotic Pathogens Innovation Center, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
50M | 5 | |||
50M | San Juan, AL | |||
50M | 19 | |||
50M | 3 | 2013 | ||
50M | 8 | 2022 |